Ligand Shaping in Induced Fit Docking of MraY Inhibitors. Polynomial Discriminant and Laplacian Operator as Biological Activity Descriptors

Int J Mol Sci. 2017 Jun 27;18(7):1377. doi: 10.3390/ijms18071377.

Abstract

Docking-i.e., interaction of a small molecule (ligand) with a proteic structure (receptor)-represents the ground of drug action mechanism of the vast majority of bioactive chemicals. Ligand and receptor accommodate their geometry and energy, within this interaction, in the benefit of receptor-ligand complex. In an induced fit docking, the structure of ligand is most susceptible to changes in topology and energy, comparative to the receptor. These changes can be described by manifold hypersurfaces, in terms of polynomial discriminant and Laplacian operator. Such topological surfaces were represented for each MraY (phospho-MurNAc-pentapeptide translocase) inhibitor, studied before and after docking with MraY. Binding affinities of all ligands were calculated by this procedure. For each ligand, Laplacian and polynomial discriminant were correlated with the ligand minimum inhibitory concentration (MIC) retrieved from literature. It was observed that MIC is correlated with Laplacian and polynomial discriminant.

Keywords: MraY; Quantitative Structure Activity Relationship (QSAR); antibiotics; docking; manifold.

MeSH terms

  • Algorithms
  • Anti-Bacterial Agents / pharmacology*
  • Bacteria / drug effects
  • Bacteria / enzymology*
  • Bacterial Infections / drug therapy
  • Bacterial Infections / microbiology
  • Bacterial Proteins / antagonists & inhibitors*
  • Bacterial Proteins / metabolism*
  • Discriminant Analysis
  • Enzyme Inhibitors / pharmacology
  • Escherichia coli / drug effects
  • Escherichia coli / enzymology
  • Humans
  • Ligands
  • Microbial Sensitivity Tests
  • Molecular Docking Simulation
  • Quantitative Structure-Activity Relationship
  • Structure-Activity Relationship
  • Transferases (Other Substituted Phosphate Groups)
  • Transferases / antagonists & inhibitors*
  • Transferases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Enzyme Inhibitors
  • Ligands
  • Transferases
  • Transferases (Other Substituted Phosphate Groups)
  • mraY protein, Bacteria